Psyence Biomedical Ltd. [NASDAQ: PBM] stock went on a downward path that fall over -3.36% on Wednesday, amounting to a one-week price increase of more than 0.62%.
Over the last 12 months, PBM stock dropped by -96.14%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $5.24 million, with 13.39 million shares outstanding and 4.70 million shares in the current float. Compared to the average trading volume of 517.82K shares, PBM stock reached a trading volume of 15393627 in the most recent trading day, which is why market watchdogs consider the stock to be active.
PBM Stock Performance Analysis:
Psyence Biomedical Ltd. [PBM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.62. With this latest performance, PBM shares gained by 5.36% in over the last four-week period, additionally sinking by -94.22% over the last 6 months – not to mention a drop of -96.14% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PBM stock in for the last two-week period is set at 44.22, with the RSI for the last a single of trading hit 49.64, and the three-weeks RSI is set at 40.89 for Psyence Biomedical Ltd. [PBM]. The present Moving Average for the last 50 days of trading for this stock 0.5677, while it was recorded at 0.4056 for the last single week of trading.
Insight into Psyence Biomedical Ltd. Fundamentals:
Psyence Biomedical Ltd.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.01 and a Current Ratio set at 0.01.
Psyence Biomedical Ltd. [PBM] Institutonal Ownership Details
The top three institutional holders of PBM stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in PBM stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in PBM stock with ownership which is approximately 5.1238%.
